Aviva’s Insmed INSM Stock Holding History

Aviva’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.4M	Buy	144,131 +22,057	+18%	+$2.67M	0.02%	471
2026 Q1	$20M	Buy	122,074 +12,673	+12%	+$1.95M	0.03%	402
2025 Q4	$19M	Buy	+109,401	New	+$20M	0.03%	406

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Aviva's INSM Position: Q2 2026 in Review

Aviva increased its Insmed (INSM) stake by 18% in Q2 2026, buying an estimated $2.67M and bringing the position to 144,131 shares worth $15.4M. The position accounts for 0.02% of the portfolio, ranked #471.

Aviva first reported a position in INSM in Q4 2025 and has held it in 3 quarters since. The position peaked at $20M in Q1 2026. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Aviva held 144,131 shares of Insmed worth $15.4M as of Q2 2026.
Aviva bought 22,057 Insmed shares in Q2 2026, an estimated $2.67M.
Insmed made up 0.02% of Aviva's portfolio in Q2 2026, its #471 holding.
Aviva first reported a position in Insmed in Q4 2025 and has held it in 3 quarters since.
Aviva's Insmed position peaked at $20M in Q1 2026.
663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.